Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-6.63	41.14	44.07
Graham Fair Price	-6.21	216258.37	230579.36
PEG	66.74	-0.08	0.05
Price/Book	13.50	1.24	1.09
Price/Cash Flow	17.05	71.08	60.73
Prices/Earnings	31.10	15.92	-12.14
Price/Sales	3.72	3.93	3.78
Price/FCF	17.05	71.08	60.73
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.35	0.52	0.49
Operating Margin	147.98	0.09	0.04
ROA	-15.25	0.01	-0.02
ROE	-0.02	0.02	-13.42
ROIC	0.01	0.02	84.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	-0.15	-17.96
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.57	1.74	204.23
EPS QOQ	-2.45	1.93	-21.38
FCF QOQ	0.25	-0.02	-90.87
Revenue QOQ	-0.10	0.10	0.54
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.43	95.00	-5.41
Days Sales Outstanding (DSO)	32.99	36.43	10.43
Inventory Turnover	0.90	0.95	5.72
Debt/Capitalization	0.04	0.07	76.44
Quick Ratio	1.38	1.39	1.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	324268.13	326850.12	0.80
Cash	55325.59	61989.48	12.04
Capex	-2355.68	-3041.11	-29.10
Free Cash Flow	5829.13	5697.51	-2.26
Revenue	93531.32	103168.74	10.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.23	2.15	-3.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.63	-3.80	17.94
Naive Interpretation	Member

06 - Financial Health · Bad

Rating